TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Automated SMS Reminders to Parents on Their Cell Phones Can Significantly Improve the on Time Vaccination Rates for Children in Pakistan
Brief Summary: Vaccines are one of the best public health tools available to achieve the Millennium Development Goal (MDG) # 4 of decreasing child mortality. A major reason for poor childhood vaccine coverage is the lack of awareness among parents regarding the need for immunization in children, and the importance of completing the entire series of vaccines. This result in significant drop-out between vaccines delivered at birth and later in the infancy period. New innovative methods involving technologies are needed to be employed to increase the vaccine coverage. This study is being conducted in Karachi, Pakistan and main study objective is

• To assess the effectiveness of SMS reminders on cell phones in improving the compliance of subsequent visits for routine immunization for children.


Options:
A: Arm Label: cMM and Text Messaging; Type: OTHER; Interventions: Behavioral: cMM, Behavioral: Text Messaging | Arm Label: cMM Only; Type: OTHER; Interventions: Behavioral: cMM | Arm Label: Text Messaging Only; Type: OTHER; Interventions: Behavioral: Text Messaging | Arm Label: Neither cMM nor Text Messaging; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: cMM; Assigned to Arm(s): cMM Only, cMM and Text Messaging | Intervention Type: BEHAVIORAL; Name: Text Messaging; Assigned to Arm(s): Text Messaging Only, cMM and Text Messaging
B: Arm Label: intervention; Type: EXPERIMENTAL; Interventions: Other: promotional Exclusive breastfeeding text messages | Arm Label: control; Type: OTHER; Interventions: Other: promotional Exclusive breastfeeding text messages | Intervention Type: OTHER; Name: promotional Exclusive breastfeeding text messages; Assigned to Arm(s): control, intervention
C: Arm Label: Reminder module (SMS and Phone call); Type: EXPERIMENTAL; Interventions: Behavioral: Reminder module (SMS and Phone call) | Arm Label: Photovoice; Type: EXPERIMENTAL; Interventions: Behavioral: Photovoice | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Reminder module (SMS and Phone call); Assigned to Arm(s): Reminder module (SMS and Phone call) | Intervention Type: BEHAVIORAL; Name: Photovoice; Assigned to Arm(s): Photovoice
D: Arm Label: One time standard verbal counseling; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SMS Reminders; Type: EXPERIMENTAL; Interventions: Behavioral: Short message service | Intervention Type: BEHAVIORAL; Name: Short message service; Assigned to Arm(s): SMS Reminders

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of a Culturally Competent Website on Living Kidney Donation for Hispanics
Brief Summary: The purpose of this study is to increase understanding about living kidney donation (LKD) among Hispanic/Latino patients and public by increasing knowledge and positive attitudes about LKD. Improving Hispanics' understanding about LKD will ensure that Hispanic patients and public are fully informed of the treatment options for End Stage Kidney Disease.


Options:
A: Arm Label: SCT-based behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: SCT-based behavioral intervention | Arm Label: Attention control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Attention Control | Intervention Type: BEHAVIORAL; Name: SCT-based behavioral intervention; Assigned to Arm(s): SCT-based behavioral intervention | Intervention Type: BEHAVIORAL; Name: Attention Control; Assigned to Arm(s): Attention control
B: Arm Label: Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Website Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Website Intervention | Intervention Type: BEHAVIORAL; Name: Website Intervention; Assigned to Arm(s): Website Intervention
C: Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Placebo | Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Educational Intervention, Behavioral: Placebo | Intervention Type: BEHAVIORAL; Name: Educational Intervention; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Placebo; Assigned to Arm(s): Control, Intervention
D: Arm Label: PREPARE intervention; Type: EXPERIMENTAL; Interventions: Behavioral: PREPARE Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: PREPARE Intervention; Assigned to Arm(s): PREPARE intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of a Culturally Competent Website on Living Kidney Donation for Hispanics
Brief Summary: The purpose of this study is to increase understanding about living kidney donation (LKD) among Hispanic/Latino patients and public by increasing knowledge and positive attitudes about LKD. Improving Hispanics' understanding about LKD will ensure that Hispanic patients and public are fully informed of the treatment options for End Stage Kidney Disease.


Options:
A: Arm Label: Testimonial Messaging; Type: EXPERIMENTAL; Interventions: Behavioral: Organ Donation Education: Testimonial Messaging | Arm Label: Informational Messaging; Type: EXPERIMENTAL; Interventions: Behavioral: Organ Donation Education: Informational Messaging | Arm Label: Blended Messaging; Type: EXPERIMENTAL; Interventions: Behavioral: Organ Donation Education: Blended Messaging | Intervention Type: BEHAVIORAL; Name: Organ Donation Education: Testimonial Messaging; Assigned to Arm(s): Testimonial Messaging | Intervention Type: BEHAVIORAL; Name: Organ Donation Education: Informational Messaging; Assigned to Arm(s): Informational Messaging | Intervention Type: BEHAVIORAL; Name: Organ Donation Education: Blended Messaging; Assigned to Arm(s): Blended Messaging
B: Arm Label: Motivational Interviewing; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing | Arm Label: Enhanced Standard Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Healthy Lifestyles Education | Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): Motivational Interviewing | Intervention Type: BEHAVIORAL; Name: Healthy Lifestyles Education; Assigned to Arm(s): Enhanced Standard Care
C: Arm Label: Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Website Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Website Intervention | Intervention Type: BEHAVIORAL; Name: Website Intervention; Assigned to Arm(s): Website Intervention
D: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: TALKS; Type: OTHER; Interventions: Behavioral: TALKS Social Worker Intervention | Arm Label: TALKS PLUS; Type: OTHER; Interventions: Behavioral: TALKS Social Worker Intervention, Other: Financial Assistance Intervention | Intervention Type: BEHAVIORAL; Name: TALKS Social Worker Intervention; Assigned to Arm(s): TALKS, TALKS PLUS | Intervention Type: OTHER; Name: Financial Assistance Intervention; Assigned to Arm(s): TALKS PLUS

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of a Culturally Competent Website on Living Kidney Donation for Hispanics
Brief Summary: The purpose of this study is to increase understanding about living kidney donation (LKD) among Hispanic/Latino patients and public by increasing knowledge and positive attitudes about LKD. Improving Hispanics' understanding about LKD will ensure that Hispanic patients and public are fully informed of the treatment options for End Stage Kidney Disease.


Options:
A: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Contract | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Behavioral Contract; Assigned to Arm(s): Intervention Group
B: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: mHealth; Type: EXPERIMENTAL; Interventions: Behavioral: mHealth | Intervention Type: BEHAVIORAL; Name: mHealth; Assigned to Arm(s): mHealth
C: Arm Label: Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Website Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Website Intervention | Intervention Type: BEHAVIORAL; Name: Website Intervention; Assigned to Arm(s): Website Intervention
D: Arm Label: Inform Me: web-based education tool; Type: EXPERIMENTAL; Interventions: Behavioral: Inform Me: web-based education tool | Arm Label: Control Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Inform Me: web-based education tool; Assigned to Arm(s): Inform Me: web-based education tool

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Optimizing Kidney Transplant Patients' Informed Consent for Increased Risk Donors
Brief Summary: The objective of this study is to evaluate kidney transplant candidates' comprehension about increased risk donor kidneys necessary for informed consent. We have developed a web-based tool that educates and assesses candidates' comprehension (Inform Me), as a supplement to current informed consent processes. We will then compare the effectiveness of the current informed consent processes supplemented by Inform Me, with the current consent processes alone for kidney transplant.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: iChoose Kidney Decision Aid; Type: EXPERIMENTAL; Interventions: Behavioral: iChoose Kidney Decision Aid | Intervention Type: BEHAVIORAL; Name: iChoose Kidney Decision Aid; Assigned to Arm(s): iChoose Kidney Decision Aid
B: Arm Label: Alert; Type: EXPERIMENTAL; Interventions: Other: Alert | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Alert; Assigned to Arm(s): Alert
C: Arm Label: Traditional Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: eNephro Application; Type: EXPERIMENTAL; Interventions: Device: Telemedicine System | Intervention Type: DEVICE; Name: Telemedicine System; Assigned to Arm(s): eNephro Application
D: Arm Label: Inform Me: web-based education tool; Type: EXPERIMENTAL; Interventions: Behavioral: Inform Me: web-based education tool | Arm Label: Control Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Inform Me: web-based education tool; Assigned to Arm(s): Inform Me: web-based education tool

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Optimizing Kidney Transplant Patients' Informed Consent for Increased Risk Donors
Brief Summary: The objective of this study is to evaluate kidney transplant candidates' comprehension about increased risk donor kidneys necessary for informed consent. We have developed a web-based tool that educates and assesses candidates' comprehension (Inform Me), as a supplement to current informed consent processes. We will then compare the effectiveness of the current informed consent processes supplemented by Inform Me, with the current consent processes alone for kidney transplant.


Options:
A: Arm Label: Symptom management nurse intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Symptom management nurse intervention | Arm Label: Feedback intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Feedback intervention | Intervention Type: BEHAVIORAL; Name: Symptom management nurse intervention; Assigned to Arm(s): Symptom management nurse intervention | Intervention Type: BEHAVIORAL; Name: Feedback intervention; Assigned to Arm(s): Feedback intervention
B: Arm Label: Integrated Chronic Kidney Disease care; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated Chronic Kidney Disease care | Arm Label: Conventional CKD care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Conventional CKD care | Intervention Type: BEHAVIORAL; Name: Integrated Chronic Kidney Disease care; Assigned to Arm(s): Integrated Chronic Kidney Disease care | Intervention Type: BEHAVIORAL; Name: Conventional CKD care; Assigned to Arm(s): Conventional CKD care
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Behavioral Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Interventions for Dialysis Facilities | Intervention Type: BEHAVIORAL; Name: Behavioral Interventions for Dialysis Facilities; Assigned to Arm(s): Behavioral Intervention
D: Arm Label: Inform Me: web-based education tool; Type: EXPERIMENTAL; Interventions: Behavioral: Inform Me: web-based education tool | Arm Label: Control Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Inform Me: web-based education tool; Assigned to Arm(s): Inform Me: web-based education tool

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetic and Biomarker Profiles of Dupilumab (REGN668) Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Brief Summary: To assess the efficacy of multiple dupilumab dose-regimens, compared to placebo, in adult participants with moderate-to-severe atopic dermatitis (AD).


Options:
A: Arm Label: Placebo qw; Type: EXPERIMENTAL; Interventions: Drug: Placebo | Arm Label: Dupilumab 300 mg qw; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab | Arm Label: Dupilumab 300 mg q2w; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab, Drug: Placebo | Arm Label: Dupilumab 200 mg q2w; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab, Drug: Placebo | Arm Label: Dupilumab 300 mg q4w; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab, Drug: Placebo | Arm Label: Dupilumab 100 mg q4w; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab, Drug: Placebo | Intervention Type: DRUG; Name: Dupilumab; Assigned to Arm(s): Dupilumab 100 mg q4w, Dupilumab 200 mg q2w, Dupilumab 300 mg q2w, Dupilumab 300 mg q4w, Dupilumab 300 mg qw | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Dupilumab 100 mg q4w, Dupilumab 200 mg q2w, Dupilumab 300 mg q2w, Dupilumab 300 mg q4w, Placebo qw
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ciclosporin | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Methotrexate | Intervention Type: DRUG; Name: Ciclosporin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Methotrexate; Assigned to Arm(s): 2
C: Arm Label: Placebo; Type: EXPERIMENTAL; Interventions: Drug: Placebo (for Dupilumab) | Arm Label: Dupilumab 300 mg once weekly (qw); Type: EXPERIMENTAL; Interventions: Drug: Dupilumab | Arm Label: Dupilumab 300 mg every 2 weeks (q2w); Type: EXPERIMENTAL; Interventions: Drug: Dupilumab, Drug: Placebo (for Dupilumab) | Intervention Type: DRUG; Name: Dupilumab; Assigned to Arm(s): Dupilumab 300 mg every 2 weeks (q2w), Dupilumab 300 mg once weekly (qw) | Intervention Type: DRUG; Name: Placebo (for Dupilumab); Assigned to Arm(s): Dupilumab 300 mg every 2 weeks (q2w), Placebo
D: Arm Label: Placebo qw; Type: EXPERIMENTAL; Interventions: Drug: Placebo (for Dupilumab), Other: Topical Corticosteroid (TCS) | Arm Label: Dupilumab 300 mg q2w; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab, Drug: Placebo (for Dupilumab), Other: Topical Corticosteroid (TCS) | Arm Label: Dupilumab 300 mg qw; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab, Other: Topical Corticosteroid (TCS) | Intervention Type: DRUG; Name: Dupilumab; Assigned to Arm(s): Dupilumab 300 mg q2w, Dupilumab 300 mg qw | Intervention Type: DRUG; Name: Placebo (for Dupilumab); Assigned to Arm(s): Dupilumab 300 mg q2w, Placebo qw | Intervention Type: OTHER; Name: Topical Corticosteroid (TCS); Assigned to Arm(s): Dupilumab 300 mg q2w, Dupilumab 300 mg qw, Placebo qw

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The purpose of this study is to determine whether providing increased protein to premature infants in the first week of life allows for better growth during the hospital stay and improved developmental outcomes by age 2.


Options:
A: Arm Label: Amino acid based formula; Type: ACTIVE_COMPARATOR; Interventions: Other: Special Medical Food | Arm Label: New amino acid based formula; Type: ACTIVE_COMPARATOR; Interventions: Other: Special Medical Food | Intervention Type: OTHER; Name: Special Medical Food; Assigned to Arm(s): Amino acid based formula | Intervention Type: OTHER; Name: Special Medical Food; Assigned to Arm(s): New amino acid based formula
B: Arm Label: Reference group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Control formula; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard infant formula | Arm Label: Formula with 50% Osteopontin; Type: ACTIVE_COMPARATOR; Interventions: Other: Infant formula supplemented with bovine milk Osteopontin | Arm Label: Formula with 100% Osteopontin; Type: ACTIVE_COMPARATOR; Interventions: Other: Infant formula supplemented with bovine milk Osteopontin | Intervention Type: OTHER; Name: Infant formula supplemented with bovine milk Osteopontin; Assigned to Arm(s): Formula with 100% Osteopontin, Formula with 50% Osteopontin | Intervention Type: OTHER; Name: Standard infant formula; Assigned to Arm(s): Control formula
C: Arm Label: Standard amino acids; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amino acids | Arm Label: High amino acids; Type: EXPERIMENTAL; Interventions: Drug: Amino acids | Intervention Type: DRUG; Name: Amino acids; Assigned to Arm(s): High amino acids, Standard amino acids
D: Arm Label: Cysteine; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Parenteral cysteine-HCl supplementation | Arm Label: No-cysteine placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo - added premasol | Intervention Type: DIETARY_SUPPLEMENT; Name: Parenteral cysteine-HCl supplementation; Assigned to Arm(s): Cysteine | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo - added premasol; Assigned to Arm(s): No-cysteine placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of the Effect of Cranberry-lingonberry Juice on the Occurrence of Urinary Tract Infections, the Gut Microbiota, and the Uropathogenic Escherichia Coli
Brief Summary: Cranberry and cranberry-lingonberry juice prevented urinary tract infections in children and in adults in our earlier clinical trials. The preventive effect was, however, observed late in the follow-up and the next recurrence was not prevented in children. The investigators hypothesize that cranberry-lingonberry juice should be started already during the antimicrobial treatment of acute urinary tract infection in order to maximize the preventive efficacy of the juice. In addition, the investigators aim to find the explanation for the efficacy of cranberry-lingonberry juice by analyzing the concomitant changes in the chemical composition of urine and feces as well as the changes of gut microbiota.


Options:
A: Arm Label: Cranberry-lingonberry juice; Type: EXPERIMENTAL; Interventions: Other: Cranberry-lingonberry juice | Arm Label: Placebo juice; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo juice | Intervention Type: OTHER; Name: Cranberry-lingonberry juice; Assigned to Arm(s): Cranberry-lingonberry juice | Intervention Type: OTHER; Name: Placebo juice; Assigned to Arm(s): Placebo juice
B: Arm Label: Cranberry powder capsules; Type: EXPERIMENTAL; Interventions: Drug: Cranberry powder capsules | Arm Label: Placebo capsules; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo powder capsules | Intervention Type: DRUG; Name: Cranberry powder capsules; Assigned to Arm(s): Cranberry powder capsules | Intervention Type: DRUG; Name: Placebo powder capsules; Assigned to Arm(s): Placebo capsules
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Cranberry; Type: EXPERIMENTAL; Interventions: Drug: Cranberry | Intervention Type: DRUG; Name: Cranberry; Assigned to Arm(s): Cranberry | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Dietary Supplement: WelTract | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: WelTract; Assigned to Arm(s): Treatment | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Control

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Diabetes Medication Choice Cards Trial in Greece
Brief Summary: A cluster randomized trial to assess the efficacy of the Diabetes Medication Choice decision aid among Greek patients with type 2 diabetes mellitus compared with usual care. The tool will serve as a facilitator for the Shared Decision Making process.


Options:
A: Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Basic medication therapy management; Type: EXPERIMENTAL; Interventions: Behavioral: Basic medication therapy management | Arm Label: Enhanced medication therapy management; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced medication therapy management | Intervention Type: BEHAVIORAL; Name: Basic medication therapy management; Assigned to Arm(s): Basic medication therapy management | Intervention Type: BEHAVIORAL; Name: Enhanced medication therapy management; Assigned to Arm(s): Enhanced medication therapy management
B: Arm Label: Diabetes Medication Choice Decision Aid; Type: EXPERIMENTAL; Interventions: Other: Diabetes Medication Choice decision aid | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Diabetes Medication Choice decision aid; Assigned to Arm(s): Diabetes Medication Choice Decision Aid
C: Arm Label: behavioral intervention, counseling; Type: EXPERIMENTAL; Interventions: Behavioral: culturally tailored diabetes education | Arm Label: delyed intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: culturally tailored diabetes education; Assigned to Arm(s): behavioral intervention, counseling
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Full drug coverage | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual coverage | Intervention Type: OTHER; Name: Full drug coverage; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Usual coverage; Assigned to Arm(s): 2

Answer: B